Related Experiment Video
Updated: Aug 15, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Heart failure in African Americans
1Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9047, USA. clyde.yancy@utsouthwestern.edu
Insights
Cardiovascular disease (CVD) disproportionately affects African Americans. This review highlights unique CVD characteristics in this population and calls for targeted treatments to reduce health disparities.
Area of Science:
- Cardiology
- Public Health
- Health Disparities
Background:
- The United States population is diversifying, necessitating increased attention to cardiovascular disease (CVD) in minority groups.
- African Americans experience a disproportionately high burden of heart failure (HF), a significant public health concern.
Purpose of the Study:
- To review the unique aspects of CVD in African Americans.
- To emphasize the need for tailored therapeutic strategies to mitigate the excess CVD burden in this demographic.
Main Methods:
- Literature review of existing studies on CVD demographics and treatment in African Americans.
- Analysis of the current understanding of heart failure pathophysiology and treatment efficacy in diverse populations.
Main Results:
- African Americans face a higher prevalence and incidence of heart failure compared to other racial/ethnic groups.
- Existing standard treatments for heart failure may have varying efficacy or require specific considerations within the African American population.
Conclusions:
- Targeted research and treatment approaches are crucial to address the unique CVD burden in African Americans.
- Reducing CVD disparities requires a deeper understanding of genetic, environmental, and socioeconomic factors influencing disease presentation and progression.
Abstract:
The demographics of the United States are changing, and in the next few decades there will no longer be a racial/ethnic majority population. Increased awareness of cardiovascular disease (CVD) in special populations is warranted as these populations increase. Heart failure carries a substantial burden on those affected, particularly African Americans, who have a disproportionate burden of heart disease. Current treatments for heart failure include angiotensin-converting enzyme inhibitors, beta-blockers, angiotensin II-receptor antagonists, and vasodilating agents. This review discusses the unique characteristics of CVD in African Americans and addresses the need for targeted treatments to reduce the excess burden found in this population.
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...